» Articles » PMID: 22804624

Mesenchymal Stromal Cells: a Key Player in 'innate Tolerance'?

Overview
Journal Immunology
Date 2012 Jul 19
PMID 22804624
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

The existence of a mesenchymal stromal cell (MSC) population with the main property of physically supporting parenchymal tissues has long been recognized in virtually all organs. However, it was only recently that MSC have been identified as playing a novel role in modulating inflammation. It has been extensively documented that, under particular circumstances, MSC potently impair virtually all cells of the immune system, including antigen-presenting-cells.

Citing Articles

Efficacy of mesenchymal stromal cells in the treatment of unexplained recurrent spontaneous abortion in mice: An analytical and systematic review of meta-analyses.

Zhao X, Hu Y, Xiao W, Ma Y, Shen D, Jiang Y PLoS One. 2023; 18(11):e0294855.

PMID: 38011163 PMC: 10681256. DOI: 10.1371/journal.pone.0294855.


Human Amniotic Mesenchymal Stem Cells Inhibit aGVHD by Regulating Balance of Treg and T Effector Cells.

Gao Y, Li W, Bu X, Xu Y, Cai S, Zhong J J Inflamm Res. 2021; 14:3985-3999.

PMID: 34429630 PMC: 8378934. DOI: 10.2147/JIR.S323054.


Mesenchymal Stem Cell Enhances the Function of MDSCs in Experimental Sjögren Syndrome.

Tian J, Hong Y, Zhu Q, Zhou H, Zhang Y, Shen Z Front Immunol. 2021; 11:604607.

PMID: 33414787 PMC: 7782428. DOI: 10.3389/fimmu.2020.604607.


Tolerance to Bone Marrow Transplantation: Do Mesenchymal Stromal Cells Still Have a Future for Acute or Chronic GvHD?.

Introna M, Golay J Front Immunol. 2020; 11:609063.

PMID: 33362797 PMC: 7759493. DOI: 10.3389/fimmu.2020.609063.


Role of the CXCR4-SDF1-HMGB1 pathway in the directional migration of cells and regeneration of affected organs.

Haque N, Fareez I, Fong L, Mandal C, Abu Kasim N, Kacharaju K World J Stem Cells. 2020; 12(9):938-951.

PMID: 33033556 PMC: 7524697. DOI: 10.4252/wjsc.v12.i9.938.


References
1.
Prockop D . Marrow stromal cells as stem cells for nonhematopoietic tissues. Science. 1997; 276(5309):71-4. DOI: 10.1126/science.276.5309.71. View

2.
Kong Q, Sun B, Bai S, Zhai D, Wang G, Liu Y . Administration of bone marrow stromal cells ameliorates experimental autoimmune myasthenia gravis by altering the balance of Th1/Th2/Th17/Treg cell subsets through the secretion of TGF-beta. J Neuroimmunol. 2009; 207(1-2):83-91. DOI: 10.1016/j.jneuroim.2008.12.005. View

3.
Groh M, Maitra B, Szekely E, Koc O . Human mesenchymal stem cells require monocyte-mediated activation to suppress alloreactive T cells. Exp Hematol. 2005; 33(8):928-34. DOI: 10.1016/j.exphem.2005.05.002. View

4.
Ren G, Zhang L, Zhao X, Xu G, Zhang Y, Roberts A . Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell. 2008; 2(2):141-50. DOI: 10.1016/j.stem.2007.11.014. View

5.
Polchert D, Sobinsky J, Douglas G, Kidd M, Moadsiri A, Reina E . IFN-gamma activation of mesenchymal stem cells for treatment and prevention of graft versus host disease. Eur J Immunol. 2008; 38(6):1745-55. PMC: 3021120. DOI: 10.1002/eji.200738129. View